diabetes - Nursing Case Study

Pathophysiology

• Primary mechanism: Insulin Resistance - In type 2 diabetes, cells in muscles, fat, and liver become resistant to insulin, meaning they don't respond effectively to insulin and can't easily absorb glucose from the bloodstream, leading to hyperglycemia.

• Secondary mechanism: Insufficient Insulin Production - The pancreas cannot produce enough insulin to overcome the resistance in cells, further exacerbating high blood sugar levels and overwhelming the body's ability to manage glucose.

• Key complication: Microvascular Damage - Chronic hyperglycemia leads to damage in small blood vessels, causing complications such as diabetic retinopathy, nephropathy, and neuropathy, which are critical concerns in diabetic patient care.

Patient Profile

Demographics:

52-year-old male, office manager

History:

• Key past medical history: Type 2 diabetes diagnosed 8 years ago, hypertension, hyperlipidemia

• Current medications: Metformin, Lisinopril, Atorvastatin, Aspirin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increasing fatigue and numbness in feet

• Key symptoms: Blurred vision, frequent urination, slow-healing foot ulcer

• Vital signs: Blood pressure 148/92 mmHg, heart rate 88 bpm, respiratory rate 18 breaths per minute, temperature 98.6°F, blood glucose 210 mg/dL

Section 1

As the healthcare team conducts an initial assessment, it becomes evident that the patient's condition is more concerning than initially anticipated. During the physical examination, the nurse notes that the patient's foot ulcer appears more extensive, with signs of infection including increased redness, swelling, and purulent discharge. The patient reports significant discomfort in the area, and the surrounding tissue is warm to touch, suggesting cellulitis. Further assessment reveals decreased sensation in both feet, consistent with peripheral neuropathy, a common complication of prolonged diabetes. This neuropathy likely contributed to the unnoticed progression of the ulcer.

Simultaneously, the nurse reviews the patient's recent laboratory results, which highlight several areas of concern. The Hemoglobin A1c level is at 9.2%, indicating poor long-term glycemic control. The patient's renal function tests show elevated creatinine levels at 1.6 mg/dL, raising concerns about early diabetic nephropathy. Additionally, his lipid profile remains suboptimal, with an LDL cholesterol level of 140 mg/dL, despite ongoing atorvastatin therapy. These findings suggest the need for a comprehensive review of his current management plan, including potential medication adjustments and lifestyle interventions focused on tighter glycemic, blood pressure, and lipid control.

The healthcare team decides to address the identified complications by enhancing the patient's treatment regimen. Immediate interventions include initiating a more aggressive wound care protocol for the foot ulcer and considering the addition of antibiotics to treat the suspected infection. The patient's metformin dosage may be reevaluated, and the introduction of a second oral hypoglycemic agent or insulin therapy is considered to better manage his hyperglycemia. A referral to a podiatrist and a diabetes educator is also planned to provide specialized care and education aimed at preventing future complications. The team emphasizes the importance of regular follow-up appointments to closely monitor the patient's progress and adjust treatment strategies as needed.

Section 2

Following the initiation of the enhanced treatment regimen, the healthcare team closely monitors the patient's response to the interventions. Within 48 hours, the patient begins intravenous antibiotic therapy targeting the cellulitis and suspected wound infection. The patient is also started on a combination therapy of metformin and a newly introduced SGLT2 inhibitor to improve glycemic control. Despite these efforts, the patient's condition shows mixed results, prompting further clinical reasoning.

On reassessment, the patient's vital signs indicate a low-grade fever of 100.4°F and a slightly elevated heart rate at 98 beats per minute, suggesting a systemic response to the infection. However, the area around the foot ulcer shows mild improvement; the redness has receded slightly, and the purulent discharge is lessening. The patient's pain levels have slightly decreased with analgesic support, yet the patient reports persistent fatigue and a mild headache. Blood glucose monitoring reveals fluctuations, with readings ranging from 180 to 250 mg/dL, indicating ongoing challenges in achieving optimal glycemic control.

Further laboratory tests conducted after the initial interventions indicate a slight decrease in creatinine levels to 1.5 mg/dL, suggesting early positive renal response. However, inflammatory markers such as C-reactive protein (CRP) remain elevated, highlighting the ongoing systemic inflammatory process. Given these findings, the healthcare team considers adding an adjunct therapy to further manage the patient's infection and discusses the potential benefits of insulin therapy for more precise blood glucose management. Additionally, the team plans to intensify patient education on lifestyle modifications, emphasizing the importance of dietary changes, foot care, and consistent medication adherence, to support long-term health outcomes. These steps aim to stabilize the patient's current condition and prevent the onset of new complications.

Section 3

As the healthcare team continues to monitor the patient's progress, a new complication emerges that prompts further clinical reasoning. Despite initial signs of improvement, the patient begins to exhibit symptoms suggestive of dehydration, likely exacerbated by the diuretic effect of the SGLT2 inhibitor. The patient reports increased thirst and a decrease in urine output. Upon examination, the patient's mucous membranes appear dry, and skin turgor is decreased. Vital signs reveal a slight drop in blood pressure to 98/60 mmHg, with a heart rate that has increased further to 104 beats per minute, indicating a possible compensatory response.

Laboratory results highlight an increase in serum sodium levels to 148 mmol/L and a slight rise in blood urea nitrogen (BUN) to 25 mg/dL, both suggestive of dehydration and potential electrolyte imbalance. Although the patient's blood glucose levels remain inconsistent, a recent reading of 265 mg/dL indicates the need for tighter glycemic control. In light of these findings, the healthcare team decides to adjust the treatment plan by initiating a fluid replacement strategy and considering a temporary reduction in the SGLT2 inhibitor dosage. Additionally, they deliberate the initiation of a basal-bolus insulin regimen to achieve more stable glycemic control.

The team also revisits the patient's education plan, emphasizing the importance of recognizing signs of dehydration and maintaining adequate hydration, especially with the current medication regimen. They reinforce the need for regular foot inspections to prevent further complications and stress the importance of nutritional adjustments to better manage blood sugar levels. These interventions aim to address the immediate complications while supporting long-term management, providing a comprehensive approach to stabilize the patient's condition and improve overall outcomes.

Section 4

Response to Interventions:

Following the adjustment of the treatment plan, the healthcare team closely monitors the patient's response to the fluid replacement strategy and the modified medication regimen. Over the next 24 hours, the patient receives intravenous isotonic saline to address the dehydration, and the SGLT2 inhibitor dosage is temporarily reduced. The patient's hydration status begins to improve, evidenced by a slight increase in urine output and a reduction in serum sodium levels to 144 mmol/L. Vital signs show a stabilization in blood pressure at 105/65 mmHg, and a slight decrease in heart rate to 98 beats per minute, indicating a positive response to the interventions.

The newly initiated basal-bolus insulin regimen is carefully titrated, resulting in improved glycemic control with recent blood glucose readings averaging around 180 mg/dL. The patient reports feeling less thirsty and more energetic, suggesting an overall improvement in their condition. However, the healthcare team remains vigilant for any signs of hypoglycemia, given the introduction of the insulin regimen. Regular blood glucose monitoring is emphasized, and the patient is educated on recognizing symptoms of both hypo- and hyperglycemia.

Despite these positive developments, the healthcare team continues to address the patient's nutritional management, aiming to optimize dietary intake to further stabilize blood glucose levels. Nutritional counseling sessions are scheduled, focusing on balanced meal planning and carbohydrate counting. The team also emphasizes the importance of ongoing self-monitoring and adherence to prescribed therapies to prevent future complications. As the patient demonstrates understanding and compliance, the healthcare team remains cautiously optimistic about the patient's progress, while remaining prepared to adjust the care plan as needed.

Section 5

As the patient continues to receive care, the healthcare team observes a new development in the patient's condition. On the third day of hospitalization, the patient starts to exhibit signs of a potential complication. The patient reports experiencing increased pain and warmth in the left lower extremity. Upon examination, the healthcare team notes erythema and swelling in the area, raising concerns about a possible infection. The patient's temperature has risen slightly to 100.4°F, and laboratory tests reveal an elevated white blood cell count of 13,000/mm³, suggesting an inflammatory response. These findings prompt the healthcare team to consider the possibility of diabetic foot infection, a common complication in patients with diabetes.

In response to these new symptoms, a comprehensive assessment is conducted to determine the extent of the infection and to prevent its progression. The healthcare team orders imaging studies and blood cultures to identify the causative organism and assess for any underlying osteomyelitis. Additionally, the patient's medication regimen is reviewed, and broad-spectrum antibiotics are initiated empirically while awaiting culture results. The team emphasizes the importance of offloading pressure from the affected foot to promote healing and prevent further damage. The nursing staff conducts regular assessments to monitor for any changes in the patient's condition and to ensure that the intervention is effective.

As the patient navigates this new complication, the healthcare team remains focused on providing holistic care. They reinforce education on proper foot care and the significance of regular follow-up appointments to monitor for potential complications. The patient is encouraged to maintain optimal blood glucose levels, as improved glycemic control can aid in the healing process and reduce the risk of further infections. The clinical reasoning behind these interventions is rooted in preventing the escalation of the infection and preserving the patient's overall health, emphasizing the need for a multidisciplinary approach to managing diabetes and its complications.